杨兴霞,黄霞霞,刘婷,汪小刚,张凯帅,蔡晓庆

• 1:甘肃中医药大学第一临床医学院
• 2:中国人民解放军联勤保障部队第九四〇医院心内科

摘要(Abstract)：

植入式心电监测仪（ICM）作为心血管病诊断技术进步的产物，是一种小型皮下植入式电子设备，无需导线即可记录并远程传输患者的心电事件。随着技术发展，新一代ICM如Reveal LINQ应运而生，以其微型化、大存储和便捷植入等特点，显著提升了心律失常监测时长与诊断率，为心血管病诊疗提供全面监测信息，还通过优化个体化治疗方案，助力心血管病的长期管理，从而改善患者的预后。近年来，随着ICM在心血管领域的研究不断深化，其临床应用范围不断扩大，展现出显著优势和独特价值。ICM已广泛应用于心血管病的早期诊断和预后管理。在未来，ICM有望在提高心血管病患者的诊断和预后管理方面发挥更大的作用，为心血管病的早期发现、精准诊断和有效管理提供更有力的支持。

关键词(KeyWords)： 植入式心电监测仪;心血管病;远程监测;预后管理

Abstract:

Keywords:

基金项目(Foundation): 兰州市科技计划项目（2023-ZD-178）

作者(Author): 杨兴霞,黄霞霞,刘婷,汪小刚,张凯帅,蔡晓庆

参考文献(References)：

• [1]刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2023》概要(心血管疾病流行及介入诊疗状况)[J].中国介入心脏病学杂志,2024,32(10):541-50.DOI:10.3969/j.issn.1004-8812.2024.10.001.
• [2]Wang R,Wang Y,Lu J,et al.Forecasting cardiovascular disease risk and burden in China from 2020 to 2030:a simulation study based on a nationwide cohort[J].Heart,2025,111(5):205-211.DOI:10.1136/heartjnl-2024-324650.
• [3]Liu CT,Guo JY,Chou RH,et al.Endothelial progenitor cells and major adverse cardiovascular events in patients receiving elective coronary angiography[J].Cardiology Plus,2023,8(1):37-45.DOI:10.1097/cp9.0000000000000041.
• [4]井然.植入式心电监测仪的应用与进展[J].中国循环杂志,2018,33(11):1131-1133.DOI:10.3969/j.issn.1000-3614.2018.11.021.
• [5]黄义梅,赵璐露,华宝桐.植入式心电事件监测仪在房颤中的应用及进展[J].实用医学杂志,2024,40(21):3095-3100.DOI:10.3969/j.issn.1006-5725.2024.21.021.
• [6]Bernstein RA,Kamel H,Granger CB,et al.Effect of long-term continuous cardiac monitoring vs.usual care on detection of atrial fibrillation in patients with stroke attributed to large-or small-vessel disease:the STROKE-AF randomized clinical trial[J].JAMA,2021,325(21):2169-2177.DOI:10.1001/jama.2021.6470.
• [7]Diederichsen SZ,Xing LY,Frodi DM,et al.Prevalence and prognostic significance of bradyarrhythmias in patients screened for atrial fibrillation vs.usual care:post hoc analysis of the LOOP randomized clinical trial[J].JAMA Cardiol,2023,8(4):326-334.DOI:10.1001/jamacardio.2022.5526.
• [8] Andersen M?,Diederichsen SZ,Svendsen JH,et al.Assessment of cardiac arrhythmias using long-term continuous monitoring in patients with pulmonary hypertension[J].Int J Cardiol,2021,334:110-115.DOI:10.1016/j.ijcard.2021.03.047.
• [9] Sanders P,Pürerfellner H,Pokushalov E,et al.Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor:results from the reveal LINQ usability study[J].Heart Rhythm,2016,13(7):1425-1430.DOI:10.1016/j.hrthm.2016.03.005.
• [10]Brugada J,Katritsis DG,Arbelo E,et al.2019 ESC guidelines for the management of patients with supraventricular tachycardiathe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology(ESC)[J].Eur Heart J,2020,41(5):655-720.DOI:10.1093/eurheartj/ehz467.
• [11]Himmelreich JCL,Lucas sen WAM,Heugen M,et al.Frequent premature atrial contractions are associated with atrial fibrillation,brain ischaemia,and mo rtality:a systematic review and meta-analysis[J].Europace,2019,21(5):698-707.DOI:10.1093/europace/euy276.
• [12]Meng L,Tsiaousis G,He J,et al.Excessive supraventricular ectopic activity and adverse cardiovascular outcomes:a systematic review and meta-analysis[J].Curr Atheroscler Rep,2020,22(4):14.DOI:10.1007/s11883-020-0832-4.
• [13] Escudero-Martínez I,Morales-Caba L,Segura T.Atrial fibrillation and stroke:a review and new insights[J].Trends Cardiovasc Med,2023,33(1):23-29.DOI:10.1016/j.tcm.2021.12.001.
• [14]Granada J,Uribe W,Chyou PH,et al.Incidence and predictors of atrial flutter in the general population[J].J Am Coll Cardiol,2000,36(7):2242-2246.DOI:10.1016/s0735-1097(00)00982-7.
• [15]Chung MK,Refaat M,Shen WK,et al.Atrial fibrillation:JACC council perspectives[J].J Am Coll Cardiol,2020,75(14):1689-1713.DOI:10.1016/j.jacc.2020.02.025.
• [16] Colilla S,Crow A,Petkun W,et al.Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S.adult population[J].Am J Cardiol,2013,112(8):1142-1147.DOI:10.1016/j.amj card.2013.05.063.
• [17]Jones NR,Taylor CJ,Hobbs FDR,et al.Screening for atrial fibrillation:a call for evidence[J].Eur Heart J,2020,41(10):1075-1085.DOI:10.1093/eurheartj/ehz834.
• [18]Al Qurashi AA,Rasheed F,Siddiqi AR,et al.Insertable cardiac monitoring devices versus external cardiac monitoring for detecting atrial fibrillation and preventing the recurrence of stroke:a systematic review and meta-analysis[J].J Electrocardiol,2023,77:29-36.DOI:10.1016/j.jelectrocard.2022.11.007.
• [19] Toyoda K,Kusano K,Iguchi Y,et al.Global results of implantable loop recorder for detection of atrial fibrillation after stroke:reveal LINQ registry[J].J Am Heart Assoc,2024,13(21):e035956.DOI:10.1161/JAHA.124.035956.
• [20] Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study[J].Stroke,1991,22(8):983-988.DOI:10.1161/01.str.22.8.983.
• [21]白瑾,谢鹏昕,李延广,等.一项前瞻性队列研究:心房颤动射频消融治疗术后出现不良结局的风险因素[J].中国介入心脏病学杂志,2025,33(3):121-127.DOI:10.3969/j.issn.1004-8812.2025.03.001.
• [22]李康,丁燕生.2023年美国心房颤动指南解读——心房颤动导管消融[J].中国介入心脏病学杂志,2024,32(3):164-167.DOI:10.3969/j.issn.1004-8812.2024.03.007.
• [23]Ratajczak-Tretel B,Tancin Lambert A,Al-Ani R,et al.Atrial fibrillation in cryptogenic stroke and TIA patients in the nordic atrial fibrillation and stroke(NOR-FIB)study:mainresults[J].Eur Stroke J,2023,8(1):148-156.DOI:10.1177/23969873221123122.
• [24]Arnar DO,Mairesse GH,Boriani G,et al.Management of asymptomatic arrhythmias:a European Heart Rhythm Association(EHRA)consensus document,endorsed by the Heart Failure Association(HFA),Heart Rhythm Society(HRS),Asia Pacific Heart Rhythm Society(APHRS),Cardiac Arrhythmia Society of Southern Africa(CASSA),and Latin America Heart Rhythm Society(LAHRS)[J].Europace,2019,21(6):844-845.DOI:10.1093/europace/euz046.
• [25]孙华鑫,张玲,贾索尔·肖克热提,等.植入式心电事件监测仪在心肌梗死大鼠室性心律失常监测中的应用[J].中国心脏起搏与心电生理杂志,2.019,33(6):529-532.DOI:10.13333/j.cnki.cjcpe.2019.06.013.
• [26]张宏超.植入式心电监测仪对不明原因晕厥和心悸患者的诊断价值和预警作用:多中心前瞻性队列研究[D].北京:中国医学科学院,2022.
• [27]Correction to:Implantable loop recorders in patients with Brugada syndrome:the BruLoop study[J].Eur Heart J,2024,45(23):2104.DOI:10.1093/eurheartj/ehae273.
• [28] Chow CL,Han HC,Teh AW,et al.Continuous rhythm monitoring and signal-averaged electrocardiogram to risk stratify ventricular arrhythmia in mitral valve prolapse[J].JACC Adv,2025,4(4):101643.DOI:10.1016/j.jacadv.2025.101643.
• [29]Bezzerides VJ,Walsh A,Martuscello M,et al.The real-world utility of the LINQ implantable loop recorder in pediatric and adult congenital heart patients[J].JACC Clin Electrophysiol,2019,5(2):245-251.DOI:10.1016/j.jacep.2018.09.016.
• [30]Kuniss M,Pavlovic N,Velagic V,et al.Cryoballoon ablation vs.antiarrhythmic drugs:first-line therapy for patients with paroxysmal atrial fibrillation[J].Europace,2021,23(7):1033-1041.DOI:10.1093/europace/euab029.
• [31] Reichlin T,Kueffer T,Badertscher P,et al.Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation[J].N Engl J Med,2025,392(15):1497-1507.DOI:10.1056/NEJMoa2502280.
• [32]O'Neill L,Almorad A,El Haddad M,et al.Impact of catheter ablation on arrhythmia burden in patients with shock-resistant persistent atrial fibrillation[J].JACC Clin Electrophysiol,2023,9(10):2071-2081.DOI:10.1016/j.jacep.2023.06.004.
• [33]Pothineni NVK,Amankwah N,Santangeli P,et al.Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation[J].J Cardiovasc Electrophysiol,2021,32(2):345-353.DOI:10.1111/jce.14864.
• [34]Zuern CS,Kilias A,Berlitz P,et al.Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors[J].Pacing Clin Electrophysiol,2015,38(6):688-693.DOI:10.1111/pace.12625.
• [35]Brignole M,Moya A,de Lange FJ,et al.2018 ESC guidelines for the diagnosis and management of syncope[J].Eur Heart J,2018,39(21):1883-1948.DOI:10.1093/eurheartj/ehy037.
• [36]Brignole M,Moya A,de Lange FJ,et al.Practical instructions for the 2018 ESC guidelines for the diagnosis and management of syncope[J].Eur Heart J,2018,39(21):e43-e80.DOI:10.1093/eurheartj/ehy071.
• [37]邱林,朱航,马为,等.卵圆孔未闭相关疾病研究2023年度进展[J].中国介入心脏病学杂志,2024,32(1):9-13.DOI:10.3969/j.issn.1004-8812.2024.01.003.
• [38]Soteriades ES,Evans JC,Larson MG,et al.Incidenceand prognosis of syncope[J].N Engl J Med,2002,347(12):878-885.DOI:10.1056/NEJMoa012407.
• [39]Vashistha K,Banga A,Nestasie M,et al.Unveiling the hidden culprit:a case report on tachy-bradyarrhythmias presenting as Seizure disorders[J].Curr Cardiol Rev,2025.DOI:10.2174/011573403X344795250304084151.Online ahead of print.
• [40]Katano K,Sato Y,Mizumura T,et al.Use of an implantable loop recorder in facilitating the differential diagnosis of isolated cardiac sarcoidosis:a case report[J].Cureus,2025,17(3):e80444.DOI:10.7759/cureus.80444.
• [41] Barry D.Differential recall bias and spurious associations in case/control studies[J].Stat Med,1996,15(23):2603-2616.DOI:10.1002/(SICI)1097-0258(19961215)15:23<2603::AID-SIM371>3.0.CO;2-G.
• [42]Pistelli L,Di Cori A,Parollo M,et al.The diagnostic yield of implantable loop recorders stratified by indication:a"realworld"single-center experience[J].J Clin Med,2025,14(4):1052.DOI:10.3390/jcm14041052.
• [43]Cabanas Grandío P,Pierre B,Bisignani G,et al.Sudden arrhythmic death in patients with syncope and implantable cardiac monitor[J].Heart Rhythm O2,2024,5(11):821-824.DOI:10.1016/j.hroo.2024.09.002.
• [44]Engelke H,Willy K,Reinke F,et al.Benefits and limitations of implantable loop recorders in the very elderly[J].Pacing Clin Electrophysiol,2024,47(11):1449-1453.DOI:10.1111/pace.15071.
• [45]周游.植入式心电事件监测器的临床进展[J],中国循环杂志,2019,34(11):1134-1137.DOI:10.3969/j.issn1000-3614.2019.11.018.
• [46] Romanov A,Martinek M,Pürerfellner H,et al.Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction:results of the ARREST study[J].Europace,2018,20(2):263-270.DOI:10.1093/europace/euw344.
• [47]Alasti M,Verma K,Rangasamy K,et al.Aborted sudden cardiac death in a patient with implantable loop recorder[J].Indian Pacing Electrophysiol J,2017,17(2):50-53.DOI:10.1016/j.ipej.2017.03.005.
• [48]Bloch Thomsen PE,Jons C,Raatikainen MJ,et al.Longterm recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction:the Cardiac arrhythmias and risk stratification after acute myocardial infarction(CARISMA)study[J].Circulation,2010,122(13):1258-1264.DOI:10.1161/CIRCUL ATIONAHA.109.90214 8.
• [49] Zile MR,Kahwash R,Sarkar S,et al.A novel heart failure diagnostic risk score using a minimally invasive subcutaneous insertable cardiac monitor[J].JACC Heart Fail,2024,12(1):182-196.DOI:10.1016/j.jchf.2023.09.014.
• [50]Kahwash R,Zile MR,Chalasani P,et al.Personalized intervention strategy based on a risk score generated from subcutaneous insertable cardiac monitor:results from phase 1 of ALLEVIATE-HF[J].J Am Heart Assoc,2024,13(20):e035501.DOI:10.1161/j aha.124.035501.
• [51]Sarkar S,Koehler J,Vasudevan N.Ambulatory risk stratification for worsening heart failure in patients with reduced and preserved ej ection fraction using diagnostic parameters available in implantable cardiac monitors[J].Diagnostics(Basel),2024,14(7):771.DOI:10.3 390/diagnostics14070771.